Biotech Genprex Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules July 22, 2023
Biotech Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 22, 2023
Biotech Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA July 21, 2023
Biotech GC Biopharma’s “GC FLU” obtains vaccine approval in Egypt: First-ever approval of the company’s quadrivalent flu vaccine on the African continent July 21, 2023
Biotech US FDA Grants Orphan Drug Designation of SN Bioscience’s Nano Anti-Cancer Drug ‘SNB-101’ for Small Cell Lung Cancer July 21, 2023
Biotech BioCity announces the first patient dosed with its first-in-class CDH3-targeting ADC BC3195 in a Phase 1 Trial July 20, 2023
Biotech Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics Research Report 2023: The Evolution of SynBio Tools Fosters Funding Ecosystems, and Unlocks High-Growth Opportunities July 20, 2023
Biotech Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech July 20, 2023